More importantly, the synthesized Orai1 peptide specifically targeting NCL and blocking NCL-Orai1 interaction, attenuates the growth of breast cancer cells through the reduction of NCL-meditated SOCE. The gene discussed is NUCLEOLIN; the disease is breast carcinoma.